| Betamethasone impurity 26 | 330157-05-6 | C26H33FO7 |
| Betamethasone impurity 27 | 127034-59-7 | C22H27FO4 |
| Betamethasone impurity 28 | 2282-51-1 | C22H27FO5 |
| Betamethasone impurity 32 | 910-99-6 | C24H30O5 |
| Betamethasone impurity 36 | 2240-28-0 | C27H37FO6 |
| Betamethasone Impurity 37 | 25122-45-6 | C24H30ClFO5 |
| Betamethasone propionate | 5593-20-4 | C28H37FO7 |
| Betamethasone sodium phosphate | 151-73-5 | C22H28FNa2O8P |
| Betamethasone Tripropionate | 1186048-33-8 | C31H41FO8 |
| Betamethasone valerate EP Impurity B | Not available | C22H29FO4 |
| Betamethasone valerate EP Impurity C | Not available | C27H37FO6 |
| Betamethasone valerate EP Impurity D | Not available | C27H37BrO6 |
| Betamethasone valerate EP Impurity E | Not available | C27H37FO6 |
| Betamethasone valerate EP Impurity F | Not available | C27H36O5 |
| Betamethasone valerate EP Impurity G | Not available | C27H36BrFO6 |
| Betamethasone valerate EP Impurity H | Not available | C27H37ClO6 |
| Betamethasone valerate for system suitability | 2152-44-5 | C27H37FO6 |
| Betamethasone Valerate Imp. A (EP): Betamethasone | 378-44-9 | C22H29FO5 |
| Betamethasone Valerate Imp. E (EP): 9-Fluoro-11 ,17-dihydroxy-16 -methyl- 3,20-dioxopregna-1,4-dien-21-yl Pentanoate (Betamethasone 21-Valerate) | 2240-28-0 | C27H37FO6 |
| Betamethasone Valerate Related Compound A | 2240-28-0 | C27H37FO6 |
| Betamethasone-17-butyrate-21-propionate | 5534-02-1 | C29H39FO7 |
| Betamethasone-17-ketone (9alpha-Fluoro-11beta-hydroxy-16beta-methylandrosta-1,4-diene-3,17-dione) | Not available | C20H25FO3 |
| Betamethasone-delta17,20 21-Aldehyde (Mixture of Isomers) | 6762-45-4 | C22H27FO4 |
| Betanin | 7659-95-2 | C24H26N2O13 |
| Betanin (sweet orange flavone) | 2306-27-6 | C20H20O7 |
| Betaxolol EP Impurity A | Not available | C14H23NO2 |
| Betaxolol EP Impurity C | Not available | C15H20O3 |
| Betaxolol EP Impurity D | Not available | C12H16O2 |
| Betaxolol EP Impurity E | Not available | C18H31NO3 |
| Betaxolol for peak identification | 63659-19-8 | C18H30ClNO3 |
| Betaxolol Hydrochloride Imp. A (EP) as Hydrochloride: (2RS)-1-(4- Ethylphenoxy)-3-[(1-methylethyl)amino]- propan-2-ol Hydrochloride | 464877-45-0 | C14H24ClNO2 |
| Betaxolol Hydrochloride Imp. B (EP): (2RS)-1-[4-(2-Hydroxyethyl)- phenoxy]-3-[(1-methylethyl)amino]propan-2-ol | 62572-94-5 | C14H23NO3 |
| Betaxolol Hydrochloride Imp. C (EP): 2-[[4-[2-(Cyclopropylmethoxy)- ethyl]phenoxy]methyl]oxirane | 63659-17-6 | C15H20O3 |
| Betaxolol Hydrochloride Imp. D (EP): 4-[2-(Cyclopropylmethoxy)ethyl]- phenol | 63659-16-5 | C12H16O2 |
| Betaxolol Impurity 1 | 62572-94-5 | C14H23NO3 |
| Betaxolol Impurity 2 | 131564-69-7 | C14H23NO3 |
| Betaxolol Impurity 3 | 131564-70-0 | C14H23NO3 |
| Betaxolol impurity A | 67193-95-7 | C14H23NO2 |
| Betaxolol impurity A | 67193-95-7 | C14H23NO2 |
| Betaxolol impurity C | 63659-17-6 | C15H20O3 |
| Betaxolol Related Compound A | 67193-95-7 | C14H23NO2 |
| Betiatide impurity D | 144616-07-9 | C13H14N2O5S |
| Betiatide impurity D | 144616-07-9 | C13H14N2O5S |
| Betulinic Acid impurity 1 | 6702-41-6 | C30H50O2 |
| Bexarotene Impurity 1 | Not available | C24H28O2 |
| Bexarotene Impurity 1 | 142-30-3 | C8H14O2 |
| Bexarotene Impurity 2 | Not available | C24H28O2 |
| Bexarotene Impurity 2 | 6117-86-8 | C8H16O2 |
| Bexarotene Impurity 3 | 153559-48-9 | C25H30O2 |
| Bexarotene Impurity 4 | 153559-45-6 | C24H28O3 |
| Bexarotene Impurity 6 | 29641-87-0 | C15H22 |
| Bexarotene Impurity 8 | 1349659-55-7 | C26H32 |
| Bezafibrate EP Impurity A | 41859-57-8 | C15H14ClNO2 |
| Bezafibrate EP Impurity C | 2157488-46-3 | C20H22ClNO4 |
| Bezafibrate EP Impurity C | Not available | C20H22ClNO4 |
| Bezafibrate EP Impurity D | 41859-58-9 | C21H24ClNO4 |
| Bezafibrate EP Impurity E | Not available | C23H28ClNO4 |
| Bezafibrate Imp. A (EP): 4-Chloro-N-[2-(4- hydroxyphenyl)ethyl]benzamide (4-Chlorobenzoyltyramine) | 41859-57-8 | C15H14ClNO2 |
| Bezafibrate Imp. B (EP): 4-Chlorobenzoic Acid | Not available | C7H5ClO2 |
| Bezafibrate Imp. D (EP): Ethyl 2-[4-[2-[(4-Chloro- benzoyl)amino]ethyl]phenoxy]-2- methylpropanoate | 41859-58-9 | C21H24ClNO4 |
| Bezafibrate Impurity 6 | 41859-56-7 | C22H17Cl2NO3 |
| Bezafibrate Impurity 7 | 84491-96-3 | C15H14ClNO2 |
| Bezafibrate Impurity 8 | 883800-52-0 | C15H14ClNO2 |
| Bezafibrate Impurity 14 | 55458-78-1 | C12H17NO3 |
| Biapenem Impurity 25 | Not available | C15H18N4O4S |
| Bicalutamide EP Impurity A (Desfluoro Bicalutamide) | 90357-05-4 | C18H15F3N2O4S |
| Bicalutamide EP Impurity B (2-Fluoro-4-Desfluoro Bicalutamide) | 1159977-36-2 | C18H14F4N2O4S |
| Bicalutamide EP Impurity C (Deshydroxy Bicalutamide) | 906008-94-4 | C18H14F4N2O3S |
| Bicalutamide EP Impurity D | 654-70-6 | C8H5F3N2 |
| Bicalutamide EP Impurity E | Not available | C18H14F4N2O3S |
| Bicalutamide EP Impurity F | Not available | C18H14F4N2O3S |
| Bicalutamide EP Impurity H | 2512198-58-0 | C18H14F4N2O4S |
| Bicalutamide EP Impurity J (Bicalutamide Sulfide) | 90356-78-8 | C18H14F4N2O2S |
| Bicalutamide EP Impurity K | Not available | C24H20F6N4O6S |
| Bicalutamide EP Impurity M | 151262-57-6 | C10H11FO5S |
| Bicalutamide for system suitability | 90357-06-5 | C18H14F4N2O4S |
| Bicalutamide Imp. D (EP): 4-Amino-2-(trifluoromethyl)benzonitrile | 654-70-6 | C8H5F3N2 |
| Bicalutamide Imp. J (EP): (2RS)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4- fluorophenyl)sulfanyl]-2-hydroxy-2-methylpropanamide | 90356-78-8 | C18H14F4N2O2S |
| Bicalutamide Impurity 1 | 2200280-97-1 | C18H16F4N2O5S |
| Bicalutamide Impurity 2 | 90357-53-2 | C12H9F3N2O |
| Bicalutamide Impurity 3 | 90357-51-0 | C12H9F3N2O2 |
| Bicalutamide impurity 4 | 24115-24-0 | C7H4Br2F3N |
| Bicalutamide impurity 5 | 1806296-18-3 | C7H4Br2F3N |
| Bicalutamide impurity 6 | Not available | C18H14F4N2O3S |
| Bicalutamide Impurity 18 | 327-74-2 | C8H5F3N2 |
| Bicalutamide Impurity 19 | 367-67-9 | C7H3BrF3NO2 |
| Bicalutamide Impurity 20 | 393-36-2 | C7H5BrF3N |
| Bicalutamide impurity D | 654-70-6 | C8H5F3N2 |
| Bicalutamide Related Compound A | 945419-64-7 | C18H14F4N2O3S |
| Bicalutamide Related Compound B | 1166228-30-3 | C18H14F4N2O4S |
| Bicalutamide Sulfoxide | 945419-64-7 | C18H14F4N2O3S |
| Bictegravir Impurity 4 | 1611493-56-1 | C21H19F2N3O5 |
| Bictegravir Impurity 17 | 2411506-35-7 | C13H15NO3 |
| Bictegravir Impurity 19 | 1616342-45-0 | C15H16N2O6 |
| Bictegravir Impurity 21 | 2365156-61-0 | C21H18F3N3O9S |
| Bictegravir Impurity 22 | 124555-33-5 | C5H12ClNO |
| Bictegravir Impurity 23 | 1523530-42-8 | C5H12ClNO |
| Bictegravir Metabolite M15 | 2365156-60-9 | C27H26F3N3O11 |
| Bictegravir Related Compound 1 | 1335210-23-5 | C13H17NO8 |
| Bictegravir Related Compound 2 | 1110772-05-8 | C5H11NO |
| Bifendate-d6 | Not available | C20H18O10 |
| Bifenthrin free acid | 76023-99-9 | C9H10ClF3O2 |
| Bifeprunox impurity 1 | 70362-50-4 | C12H6Cl4 |
| Bifonazole EP Impurity A | 7598-80-3 | C19H16O |
| Bifonazole EP Impurity B | 91679-37-7 | C22H18N2 |
| Bifonazole EP Impurity D Chloride | 66600-13-3 | C41H33ClN2 |
| Bifonazole EP Impurity E | 2469554-07-0 | C41H32N2 |
| Bifonazole for system suitability | 60628-96-8 | C22H18N2 |
| Bifonazole Imp. A (EP): (RS)-(Biphenyl-4-yl)- phenylmethanol | 7598-80-3 | C19H16O |
| Bifonazole Imp. C (EP): 1H-Imidazole (Imidazole) | 288-32-4 | C3H4N2 |
| Bifonazole Imp. D (EP) as Chloride: 1,3-Bis[(biphenyl- 4-yl)phenylmethyl]-1H-imidazolium Chloride | 66600-13-3 | C41H33ClN2 |
| Bifonazole Impurity 6 | 91487-87-5 | C20H17NO |
| Bifonazole Impurity 12 | 1985-32-6 | C19H14O |
| Bifonazole Impurity 16 | 7515-73-3 | C19H15Cl |
| Bilastine Impurity 2 | 202189-83-1 | C26H33N3O3 |
| Bilastine Impurity 3 | 2818982-86-2 | C20H31N3O2 |
| Bilastine Impurity 4 | 2767508-98-3 | C27H35N3O3 |
| Bilastine Impurity 5 | 110963-63-8 | C16H23N3O |
| Bilastine Impurity 6 | 1638785-17-7 | C14H20ClNO2 |
| Bilastine Impurity 7 | 1638785-18-8 | C30H42N4O3 |
| Bilastine Impurity 8 | 1181267-38-8 | C29H39N3O3 |
| Bilastine Impurity 9 | 1181267-33-3 | C13H17ClO2 |
| Bilastine Impurity 10 | 202189-77-3 | C32H44N4O2 |
| Bilastine Impurity 11 | 1638785-19-9 | C13H15ClO3 |
| Bilastine Impurity 12 | 2099128-83-1 | C24H29N3O2 |
| Bilastine Impurity 13 | 1215537-40-8 | C28H37N3O3 |
| Bilastine Impurity 14 | 2767509-00-0 | C32H46N4O3 |
| Bilastine Impurity 18 | 2731008-04-9 | C12H14N4O |
| Bilastine Impurity 18 | 953071-73-3 | C17H23N3O2 |
| Bilastine Impurity 19 | 1181267-36-6 | C21H31N3O3 |
| Bilastine Impurity 20 | 1638785-23-5 | C28H37N3O4 |
| Bilastine Impurity 21 | 202189-76-2 | C23H29NO4S |
| Bilastine Impurity 22 | 2807304-46-5 | C16H23N3O |
| Bilastine Impurity 23 | 2411093-91-7 | C36H43N3O4 |
| Bilastine Impurity 28 | 2761944-43-6 | C13H17ClO3 |
| Bilastine Impurity 32 | Not available | C30H40N4O2 |
| Bilastine Impurity 37 | 2199440-16-7 | C12H15ClO2 |
| Bilastine Impurity 40 | 552301-45-8 | C12H16O3 |
| Bilastine Impurity 52 | 883106-63-6 | C17H25N3O3 |
| Bilastine Impurity 63 | 1000536-33-3 | C13H18O3 |
| Bilastine N-Oxide | 2069238-47-5 | C28H37N3O4 |
| Bimatoprost Acid | 38344-08-0 | C23H32O5 |
| Bimatoprost Acid Methyl Ester | 38315-47-8 | C24H34O5 |
| Bimatoprost Impurity 3 | Not available | C25H37NO5 |
| Bimatoprost Impurity 5 | 155206-01-2 | C24H35NO4 |
| Bimatoprost Impurity 6 | 41639-71-8 | C23H32O5 |
| Bimatoprost Impurity 7 | 1201226-16-5 | C25H29BrNOP |
| Bimatoprost Impurity 8 | 76704-05-7 | C8H12O4 |
| Bimatoprost Impurity 12 | 41162-19-0 | C12H17O4P |
| Bimatoprost Impurity 15 | 856240-62-5 | C18H24O4 |
| Bimatoprost Impurity 18 | 41639-74-1 | C18H22O4 |
| Bimatoprost Impurity 19 | 607351-44-0 | C25H39NO4 |
| Bimatoprost Impurity 20 | 2512198-63-7 | C19H24NO2P |
| Binimetinib | 606143-89-9 | C17H15BrF2N4O3 |
| Biopterin impurity 1 | 22150-76-1 | C9H11N5O3 |
| Biopterin impurity 5 | 71014-28-3 | C9H9N5O2 |
| Biopterin impurity 7 | 1177884-36-4 | C9H17N5O3 |
| Biopterin impurity 8 | 1797-87-1 | C9H11N5O2 |
| Biotin (R)-Sulfoxide | 3376-83-8 | C10H16N2O4S |
| Biotin (S)-Sulfoxide | 10406-89-0 | C10H16N2O4S |
| Biotin EP Impurity A | 1163708-46-0 | C18H28N4O4S2 |
| Biotin EP Impurity B | 57671-79-1 | C11H16N2O5S |
| Biotin EP Impurity C | 22342-46-7 | C9H18N2O2S |
| Biotin EP Impurity D | 415725-35-8 | C11H18N2O3S |
| Biotin EP Impurity E (1-Benzyl) | 76335-62-1 | C17H22N2O3S |
| Biotin EP Impurity E (3-Benzyl) | 57229-92-2 | C17H22N2O3S |
| Biotin EP Impurity F | 101469-35-6 | C29H36N2O5S |
| Biotin EP Impurity G Bromide | 33719-11-8 | C22H25BrN2OS |
| Biotin EP Impurity H | Not available | C12H20N2O3S |
| Biotin Impurity 1 | 171232-73-8 | C19H18N2O2S |
| Biotin Impurity 2 | 21788-37-4 | C10H16N2O3S |
| Biotin Impurity 3 | 28092-52-6 | C19H18N2O2S |
| Biotin Impurity 12 | 26339-40-2 | C19H18N2O5 |
| Biotin Impurity 13 | Not available | C24H28N2O3S |
| Biotin Impurity 16 | 28092-62-8 | C19H18N2O3 |
| Biotin Impurity 22 | 33607-60-2 | C24H28N2O3S |
| Biotin Impurity 43 | 2714810-33-8 | C12H20N2O3S |
| Biotin sulfone | 40720-05-6 | C10H16N2O5S |
| Biperiden Epoxide N-Oxide | Not available | C21H29NO3 |
| Biperiden impurity A | Not available | C21H29NO |
| Biperiden N-Oxide | Not available | C21H29NO2 |
| Biperideni hydrochloridum | 1235-82-1 | C21H30ClNO |
| Biphenyl | 92-52-4 | C12H10 |
| Biphenyl | 92-52-4 | C12H10 |
| Bis (2-ethylhexyl) Phthalate-d4 | 93951-87-2 | C24H38O4 |
| Bis (4-sulfobutyl)ether Disodium Salt | 183278-30-0 | C8H16Na2O7S2 |
| Bis Valacyclovir (~90%) | Not available | C27H40N12O8 |
| Bis(1-methylethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 21881-78-7 | C21H26N2O6 |
| Bis(1-methylethyl) 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 21881-78-7 | C21H26N2O6 |
| Bis(2-chloroethyl)amine Hydrochloride | 821-48-7 | C4H10Cl3N |
| Bis(2-methoxyethyl) 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 70172-96-2 | C21H26N2O8 |
| Bis(4-cyanophenyl)methanol | 134521-16-7 | C15H10N2O |
| Bis(4-hydroxybutyl) Terephthalate | 23358-95-4 | C16H22O6 |
| Bis(4-nitrophenyl)phenyl Phosphate | 38873-96-0 | C18H13N2O8P |
| Bis(4-sulfobutyl)ether Disodium | 183278-30-0 | C8H16Na2O7S2 |
| Bis(aminoethoxy) Amlodipine | 721958-74-3 | C22H30ClN3O6 |
| Bis(diphenylmethyl) Ether | 574-42-5 | C26H22O |
| Bis(diphenylmethyl)disulfide | 1726-02-9 | C26H22S2 |
| Bis(ethoxycarbonyl) Efavirenz Amino Alcohol | Not available | C19H19ClF3NO5 |
| Bis(heptadecafluorooctyl)phosphinic Acid | 40143-79-1 | C16HF34O2P |
| Bis-(1,7-dihydro-6<I>H</I>-purine)-6,6,-disulfide | 49808-20-0 | C10H6N8S2 |
| Bis-(1,7-dihydro-6H-purine)-6,6,-disulfide | 49808-20-0 | C10H6N8S2 |
| Bis-(2-piperidinoethyl)ether Dihydrochloride (BPEE Dihydrochloride) | 104032-34-0 | C14H30Cl2N2O |
| Bis-(6Alpha-Methylprednisolone) 21,21'-Ether | Not available | C44H58O9 |
| Bis-[Des(5-Chloro-2-carboxythienyl)] Rivaroxaban Phthalamide | 1365267-36-2 | C36H36N6O10 |
| Bis-clindamycinyl Phosphate | Not available | C36H65Cl2N4O12PS2 |
| Bis-Valacyclovir | 1356019-51-6 | C27H40N12O8 |
| Bis[3-[(2-chloroethyl)amino]propyl] Dihydrogen Diphosphate | 241482-18-8 | C10H24Cl2N2O7P2 |
| Bis[4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl] (Cyclopentane-1,1-diyl)diacetate Dioxalate | Not available | C37H54N8O12 |
| Bis[4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl] (Cyclopentane-1,1-diyl)diacetate Dioxalate | 2724726-70-7 | C37H54N8O12 |
| Bis[(1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinolinyl]-methanone | 1534326-81-2 | C31H28N2O |
| Bis[(2-guanidino-4-thiazolyl)methyl]disulfide (85%) (Famotidine Impurity) | 129083-44-9 | C10H14N8S4 |
| Bisacodyl EP Impurity A | 603-41-8 | C18H15NO2 |
| Bisacodyl EP Impurity B | 16985-05-0 | C18H15NO2 |
| Bisacodyl EP Impurity C | 72901-16-7 | C20H17NO3 |
| Bisacodyl EP Impurity E | 111664-35-8 | C22H19NO4 |
| Bisacodyl for peak identification | 603-50-9 | C22H19NO4 |
| Bisacodyl for system suitability | 603-50-9 | C22H19NO4 |
| Bisacodyl Imp. A (EP): 4,4'-(Pyridin-2-ylmethylene)- diphenol | 603-41-8 | C18H15NO2 |
| Bisacodyl Imp. B (EP): 2-[(RS)-(4-Hydroxyphenyl)- (pyridin-2-yl)methyl]phenol | 16985-05-0 | C18H15NO2 |
| Bisacodyl Imp. C (EP): 4-[(RS)-(4-Hydroxyphenyl)- (pyridin-2-yl)methyl]phenyl Acetate | 72901-16-7 | C20H17NO3 |
| Bisacodyl Imp. E (EP): 2-[(RS)-[4-(Acetyloxy)phenyl]- (pyridin-2-yl)methyl]phenyl Acetate 4-[(RS)-(4-Hydroxyphenyl)(pyridin-2-yl)- methyl]phenyl Sodium Sulphate | 111664-35-8 | C22H19NO4 |
| Bisacodyl Impurity 5 | 13004-51-8 | C18H15NO2 |
| Bisacodyl Impurity 6 | 109810-81-3 | C18H15NO2 |
| Bisacodyl Related Compound B | 16985-05-0 | C18H15NO2 |
| Bisacodyl Related Compound C | 72901-16-7 | C20H17NO3 |
| Bisacodyl Related Compound E | 111664-35-8 | C22H19NO4 |
| Bisnorbiotin | 16968-98-2 | C8H12N2O3S |
| Bisoctrizole Related Compound A | 3147-75-9 | C20H25N3O |
| Bisoprolol EP Impurity A | 62572-93-4 | C13H21NO3 |
| Bisoprolol EP Impurity B | 1447715-44-7 | C18H31NO4 |
| Bisoprolol EP Impurity C | 1225195-70-9 | C25H38N2O4 |
| Bisoprolol EP Impurity C | 1797132-90-1 | C23H34N2O4 |
| Bisoprolol EP Impurity D | 1225195-71-0 | C26H40N2O5 |
| Bisoprolol EP Impurity E | 1217245-60-7 | C18H29NO3 |
| Bisoprolol EP Impurity F | 1798418-82-2 | C18H31NO4 |
| Bisoprolol EP Impurity G | 1215342-36-1 | C19H33NO5 |
| Bisoprolol EP Impurity K | 864544-37-6 | C18H29NO5 |
| Bisoprolol EP Impurity N | 1346601-75-9 | C17H29NO4 |
| Bisoprolol EP Impurity Q | 1346604-00-9 | C16H27NO4 |
| Bisoprolol EP Impurity R | 5790-46-5 | C13H21NO2 |
| Bisoprolol EP Impurity T | 1173203-26-3 | C14H17NO4 |
| Bisoprolol EP Impurity U | 1071765-44-0 | C14H19NO4 |
| Bisoprolol for peak identification | 104344-23-2 | C40H66N2O12 |
| Bisoprolol for system suitability | 104344-23-2 | C40H66N2O12 |
| Bisoprolol Fumarate Imp. A (EP): (RS)-1-(4-Hydroxymethyl- phenoxy)-3-isopropylaminopropan-2-ol | 62572-93-4 | C13H21NO3 |
| Bisoprolol Fumarate Imp. B (EP): (RS)-1-Isopropylamino-3-[4-(2- propoxyethoxymethyl)phenoxy]propan-2-ol | 1447715-44-7 | C18H31NO4 |
| Bisoprolol Fumarate Imp. G (EP): (2RS)-1-[4-[[(2-Isopropoxy- ethoxy)methoxy]methyl]phenoxy]-3-iso- propylaminopropan-2-ol | 1215342-36-1 | C19H33NO5 |
| Bisoprolol Fumarate Imp. K (EP): 2-Isopropoxyethyl 4-[[(2RS)-2- Hydroxy-3-(isopropylamino)propyl]oxy]- benzoate (Bisoprolol Ester) | 864544-37-6 | C18H29NO5 |
| Bisoprolol Fumarate Imp. M (Pharmeuropa): 4-[(2-Isopropoxy- ethoxy)methyl]phenol | 177034-57-0 | C12H18O3 |
